A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

Recruiting

Phase 3

NNZ-2591A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

Sponsor:

Neuren Pharmaceuticals Limited

Code:

NCT07281079

Conditions

Phelan-McDermid Syndrome

Eligibility Criteria

Sex: All

Age: 3 - 12

Healthy Volunteers: Not accepted

Interventions

NNZ-2591

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-27. This information was provided to ClinicalTrials.gov by Neuren Pharmaceuticals Limited on 2025-12-15.